Charles M Gerrits

Summary

Affiliation: Takeda Global Research and Development Center
Country: USA

Publications

  1. ncbi A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes
    Charles M Gerrits
    Department of Global Pharmacoepidemiology, Takeda Global Research and Development, Inc, Deerfield, IL, USA
    Pharmacoepidemiol Drug Saf 16:1065-71. 2007

Collaborators

Detail Information

Publications1

  1. ncbi A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes
    Charles M Gerrits
    Department of Global Pharmacoepidemiology, Takeda Global Research and Development, Inc, Deerfield, IL, USA
    Pharmacoepidemiol Drug Saf 16:1065-71. 2007
    ..Recent studies have raised concerns about potential increased cardiovascular (CV) risk in type 2 diabetes patients treated with some peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonists...